Role of K+ channels in the coronary and renal vascular reactivity to vasopressin in diabetic rats

European Journal of Pharmacology

Volumn 471, Issue 1, 2003, Pages 35-40

  Sanz, Elena ^a   Fernández, Nuria ^a   Monge, Luis ^a   Climent, Belén ^a   Diéguez, Godofredo ^a   García Villalón, Ángel Luis ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Coronary artery; Diabetes; Gender; K+ channel; Renal artery; Vasopressin

Indexed keywords

CHARYBDOTOXIN; GLIBENCLAMIDE; POTASSIUM CHANNEL; STREPTOZOCIN; SUPEROXIDE; SUPEROXIDE DISMUTASE; VASOPRESSIN;

ANIMAL EXPERIMENT; ARTERY CONSTRICTION; ARTICLE; BLOOD VESSEL REACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORONARY ARTERY; DIABETES MELLITUS; FEMALE; KIDNEY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE;

EID: 0038519501     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)01815-6     Document Type: Article

References (27)

1. Berweck S., Lepple-Wienhues A., Stoss M., Wiederholt M. Large conductance calcium-activated potassium channels in cultured retinal pericytes under normal and high-glucose conditions. Pflügers Arch. 427:1994;9-16.
2. Bouchard J.F., Dumont E.C., Lamontagne D. Modification of vasodilator response in streptozotocin-induced diabetic rat. Can. J. Physiol. Pharm. 77:1999;980-985.
3. ATP channels in vascular smooth muscle. Clin. Exp. Pharmacol. Physiol. 29:2002;312-316.
4. Brooks D.P., Nutting D.F., Crofton J.T., Share L. Vasopressin in rats with genetic and streptozotocin-induced diabetes. Diabetes. 38:1989;54-57.
5. Douglas P.S. Coronary artery disease in women. Braunwald E. Heart Disease. A Textbook of Cardiovascular Medicine. 1997;1704-1714 Saunders, Philadelphia.
6. Farmer J.A., Gotto A.M. Dyslipidemia and other risk factors for coronary artery disease. Braunwald E. Heart Disease. A Textbook of Cardiovascular Medicine. 1997;1126-1157 Saunders, Philadelphia.
7. García-Villalón A.L., Sanz E., Monge L., Fernández N., Martínez M.A., Climent B., Diéguez G. Vascular reactivity to vasopressin during diabetes: gender and regional differences. Eur. J. Pharmacol. 459:2003;247-254.
8. + channels, in aorta from streptozotocin-treated diabetic rats. Naunyn-Schmiedeberg's Arch. Pharmacol. 356:1997;210-215.
9. Hayward C.S., Kelly R.P., Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc. Res. 46:2000;28-49.
10. Hebden R.A., Bennett T., Gardiner S.M. Pressor sensitivities to vasopressin, angiotensin II, or methoxamine in diabetic rats. Am. J. Physiol. 253:1987;R726-R734.
11. + channels on afferent arteriolar diameter in diabetes mellitus. J. Am. Soc. Nephrol. 11:2000;1199-1207.
12. Jackson W.F. Ion channels and vascular tone. Hypertension. 35:2000;173-178.
13. Kamata K., Miyata N., Kasuya Y. Functional changes in potassium channels in aortas from rats with streptozotocin-induced diabetes. Eur. J. Pharmacol. 166:1989;319-323.
14. Kersten J.R., Brooks L.A., Dellsperger K.C. Impaired microvascular response to graded coronary occlusion in diabetic and hyperglycemic dogs. Am. J. Physiol. 268:1995;H1667-H1674.
15. G-nitro-L-arginine methyl ester in streptozotocin-induced diabetes mellitus. Br. J. Pharmacol. 106:1992;1035-1040.
16. Liu Y., Gutterman D.D. Oxidative stress and potassium channel function. Clin. Exp. Pharmacol. Physiol. 29:2002;305-311.
17. + channel-mediated vasodilation. Vasc. Pharmacol. 38:2002;43-49.
18. Mayhan W.G. Effect of diabetes mellitus on response of the basilar artery to activation of ATP-sensitive potassium channels. Brain Res. 636:1994;35-39.
19. Mendelsohn M.E., Karas R.H. The protective effects of estrogen on the cardiovascular system. N. Engl. J. Med. 340:1999;1801-1811.
20. Öztürk Y., Altan V.M., Yildizoglu-Ari N. Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol. Rev. 48:1996;69-112.
21. Sanz E., Monge L., Fernández N., Martínez M.A., Diéguez G., García-Villalón A.L. Diabetes abolishes the gender difference in vasopressin-mediated potentiation of sympathetic vasoconstriction. Eur. J. Pharmacol. 427:2001;243-250.
22. Sarubbi D., McGiff J.C., Quilley J. Renal vascular responses and eicosanoid release in diabetic rats. Am. J. Physiol. 257:1989;F762-F768.
23. Sobey C.G. Potassium channel function in vascular disease. Arterioscler. Thromb. Vasc. Biol. 21:2001;28-38.
24. Vokes T.P., Aycinena P.R., Robertson G.L. Effect of insulin on osmoregulation of vasopressin. Am. J. Physiol. 252:1987;E538-E548.
25. Wang R., Wang Z., Wu L., Hanna S.T., Peterson-Wakeman R. Reduced vasorelaxant effect of carbon monoxide in diabetes and the underlying mechanisms. Diabetes. 50:2001;166-174.
26. West I.C. Radicals and oxidative stress in diabetes. Diabet. Med. 17:2000;171-180.
27. + channel openers in cerebral arteries from diabetic rats. Circ. Res. 81:1997;996-1004.